The REIMAGINE 5 NN9388-7741 Study App will collect information such as doses taken, low blood sugar episodes, participant-reported outcomes, and additional data relevant to the clinical study. Sites involved in the clinical study must create individual accounts for each participant within the study app prior to enabling participant access and login.